Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RT-M2

Home DrugsRT-M2

RT-M2

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Cell strain for stably expressing respiratory syncytial virus M2-1 protein and construction method thereof
CN 106190984 AApplicant: DONGGUAN CHILDREN'S HOSPITALPriority: 2016
CN
Application of M2 type macrophage exosome in preparation of medicine for treating osteoporosis
CN 114224915 AApplicant: UNIV ZHEJIANGPriority: 2021
CN
Application of catalpol in medicine for treating sepsis-related encephalopathy
CN 116236495 AApplicant: UNIV CHONGQING MEDICALPriority: 2023
CN
PTK7 targeted drug as well as preparation method and application thereof
CN 121800878 AApplicant: SHANGHAI HEZHOU MEDICINE CO LTDPriority: 2025
CN